These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11896510)

  • 1. Impact of calcium antagonists on bleeding time in patients with chronic renal failure.
    Hayashi K; Matsuda H; Honda M; Ozawa Y; Tokuyama H; Okubo K; Takamatsu I; Kanda T; Tatematsu S; Homma K; Saruta T
    J Hum Hypertens; 2002 Mar; 16(3):199-203. PubMed ID: 11896510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W; Dmoszyńska A; Sokołowska B
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function and the bleeding time in progressive renal failure.
    Gordge MP; Faint RW; Rylance PB; Neild GH
    Thromb Haemost; 1988 Aug; 60(1):83-7. PubMed ID: 3187950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The decreased circulating platelet mass and its relation to bleeding time in chronic renal failure.
    Michalak E; Walkowiak B; Paradowski M; Cierniewski CS
    Thromb Haemost; 1991 Jan; 65(1):11-4. PubMed ID: 2024233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Deamino-8-d-arginine vasopressin (DDAVP): a potential new treatment for the bleeding diathesis of acute renal failure.
    Watson AJ; Keogh JA
    Pharmatherapeutica; 1984; 3(9):618-22. PubMed ID: 6728864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding time in patients with chronic liver diseases].
    Michalski A; Cegłowska A; Besser P
    Wiad Lek; 1993 May; 46(9-10):337-42. PubMed ID: 8236988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lercanidipine in patients with chronic renal failure: the ZAFRA study.
    Robles NR; Ocon J; Gomez CF; Manjon M; Pastor L; Herrera J; Villatoro J; Calls J; Torrijos J; Rodríguez VI; Rodriguez MM; Mendez ML; Morey A; Martinez FI; Marco J; Liebana A; Rincon B; Tornero F
    Ren Fail; 2005; 27(1):73-80. PubMed ID: 15717638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of calcium antagonists and hemoglobin loss in hospitalized elderly patients: a cohort study. Gruppo Italiano di Farmacoepidemiologia nell'Anziano (GIFA) investigators.
    Zuccalà G; Pedone C; Cocchi A; Pahor M; Carosella L; Carbonin P; Bernabei R
    Clin Pharmacol Ther; 2000 Mar; 67(3):314-22. PubMed ID: 10741636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and renal failure progression.
    Robles NR
    Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
    Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
    Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet factor 3 in normal subjects and patients with renal failure.
    Rabiner SF; Hrodek O
    J Clin Invest; 1968 Apr; 47(4):901-12. PubMed ID: 5641625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndrome.
    Urbanus RT; de Laat HB; de Groot PG; Derksen RH
    Arthritis Rheum; 2004 Nov; 50(11):3605-9. PubMed ID: 15529374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.